Exploring Staphylococcus aureus Virulence Factors; Special Emphasis on Staphyloxanthin

키워드

참고문헌 (111)

1. Pelz A, "Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus", J. Biol. Chem, 280, pp.32493~32498 (2005)
2. Aires de Sousa M, "Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones", FEMS Immunol. Med. Microbiol, 40, pp.101~111 (2004)
3. Muto CA, "SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus", Infect. Control Hosp. Epidemiol, 24, pp.362~386 (2003)
4. Miller LG, "Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of communityassociated methicillin-resistant Staphylococcus aureus infection", Clin. Infect. Dis, 46, pp.752~760 (2008)
5. Lowy FD, "Staphylococcus aureus infections", N. Engl. J. Med, 339, pp.520~532 (1998)
6. Kazakova SV, "A clone of methicillin-resistant Staphylococcus aureus among professional football players", N. Engl. J. Med, 352, pp.468~475 (2005)
7. Gould D, "Staphylococcus aureus: a review of the literature", J. Clin. Nurs, 4, pp.5~12 (1995)
8. Kong C, "Targeting Staphylococcus aureus toxins : A potential form of anti-virulence therapy", Toxins, 8, pp.72~ (2016)
9. Baba T, "Genome and virulence determinants of high virulence community-acquired MRSA", Lancet, 359, pp.1819~1827 (2002)
10. Lowy FD, "Staphylococcus aureus infections", New Engl. J. Med, 339, pp.520~532 (1998)
11. Liñares J, "The VISA", GISA problem: therapeutic implications, 2001, pp.7(Suppl 4), 8~15
12. Garcia LG, "Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data", J. Antimicrob. Chemother, 68, pp.1455~1464 (2013)
13. Foster TJ, "The Staphylococcus aureus "superbug"", J. Clin. Investig, 114, pp.1693~1696 (2004)
14. Novick RP, "Autoinduction and signal transduction in the regulation of staphylococcal virulence", Mol. Microbiol, 48, pp.1429~1449 (2003)
15. Zhu Y, "Staphylococcus aureus virulence factors synthesis is controlled by central metabolism", Dissertations & Theses in Veterinary and Biomedical Science, 5 (2010)
16. Foster TJ, "Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus", Nat. Rev. Microbiol, 12, pp.49~62 (2014)
17. Bien J, "Characterization of virulence factors of Staphylococcus aureus: Novel function of known virulence factors that are implicated in activation of airway epithelial proinflammatory response", J. Pathog, 2011, pp.601905~ (2011)
18. Sabat A, "Distribution of the serine-aspartate repeat protein-encoding sdr genes among nasal-carriage and invasive Staphylococcus aureus strains", J. Clin. Microbiol, 44, pp.1135~1138 (2006)
19. George NP, "Staphylococcus aureus adhesion via Spa, ClfA, and SdrCDE to immobilized platelets demonstrates shear-dependent behavior", Arterioscler. Thromb. Vasc. Biol, 26, pp.2394~2400 (2006)
20. Clarke SR, "Iron-regulated surface determinant protein A mediates adhesion of Staphylococcus aureus to human corneocyte envelope proteins", Infect. Immun, 77, pp.2408~2416 (2009)
21. Clarke SR, "IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin", Infect. Immun, 76, pp.1518~1526 (2008)
22. Gómez MI, "Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1", Nat. Med, 10, pp.842~848 (2004)
23. Geoghegan JA, "Role of surface protein SasG in biofilm formation by Staphylococcus aureus", J. Bacteriol, 192, pp.5663~5673 (2010)
24. Weinstein L, "Seminars in infectious disease, 2", pp.256~303 (1982), Ed. Stratton Intercontinental Medical Book Corporation
25. Nilsson I-M, "The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis", Infect. Immun, 65, pp.4216~4221 (1997)
26. Nanra JS, "Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus", Hum. Vaccin. Immunother, 9, pp.480~487 (2013)
27. O'Riordan K, "Staphylococcus aureus capsular polysaccharides", Clin. Microbiol. Rev, 17, pp.218~234 (2004)
28. Sau S, "The Staphylococcus aureus allelic genetic loci for serotype 5 and 8capsule expression contain the type-specific genes flanked by common genes", Microbiology, 143, pp.2395~2405 (1997)
29. Parsek MR, "Bacterial biofilms: an emerging link to disease pathogenesis", Ann. Rev. Microbiol, 57, pp.677~701 (2003)
30. Kiedrowski MR, "New approaches for treating staphylococcal biofilm infections", 1241, pp.104~121 (2011)[DOI]
31. Fitzpatrick F, "Evidence for icaADBC-independent biofilm development mechanism in methicillin-resistant Staphylococcus aureus clinical isolates", J. Clin. Microbiol, 43, pp.1973~1976 (2005)
32. Donlan RM, "Biofilms: survival mechanisms of clinically relevant microorganisms", Clin. Microbiol. Rev, 15, pp.167~193 (2002)
33. Scherr TD, "Hiding in plain sight: interplay between staphylococcal biofilms and host immunity", Front. Immunol, 5, pp.37~ (2014)
34. De la Fuente-Núñez C, "Bacterial biofilm development as a multicellular adaptation:antibiotic resistance and new therapeutic strategies", Curr. Opin. Microbiol, 16, pp.580~589 (2013)
35. Costerton JW, "Bacterial biofilms : a common cause of persistent infections", Science, 284, pp.1318~1322 (1999)
36. Yarets Y, "The biofilm-forming capacity of Staphylococcus aureus from chronic wounds can be useful for determining Wound-Bed Preparation methods", EWMA J, 13, pp.7~14 (2013)
37. Otto M, "Staphylococcal biofilms", Curr. Topics Microbiol. Immunol, 322, pp.207~228 (2008)
38. Mirani ZA, "Biofilm formation and dispersal of Staphylococcus aureus under the influence of oxacillin", Microb. Pathog, 61, pp.66~72 (2013)
39. Rooijakkers SH, "Staphylococcal innate immune evasion", Trends Microbiol, 13, pp.596~601 (2005)
40. Rooijakkers SH, "Anti-opsonic properties of staphylokinase", Microb. Infect, 7, pp.476~484 (2005)
41. Lee LYL, "Inhibition of complement activation by a secreted Staphylococcus aureus protein", J. Infect. Dis, 190, pp.571~579 (2004)
42. de Haas CJ, "Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent", J. Exp. Med, 199, pp.687~695 (2004)
43. Rooijakkers SH, "Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus", Cell. Microbiol, 8, pp.1282~1293 (2006)
44. Sonnen AF, "Role of pore-forming toxins in neonatal sepsis", Clin. Dev. Immunol, 2013, pp.608456~ (2013)
45. Burnside K, "Regulation of hemolysin expression and virulence of Staphylococcus aureus by a serine", threonine kinase and phosphatase, 2010, pp.5, e11071~
46. Vandenesch F, "Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides:a redundant arsenal of membrane-damaging virulence factors?", Front. Cell. Infect. Microbiol, 2, pp.12~ (2012)
47. Lin Y-C, "New insights into the prevention of staphylococcal infections and toxic shock syndrome", Exp. Rev. Clin. Pharmacol, 3, pp.753~767 (2010)
48. Chowdhury T, "Virtual screening of compounds derived from Garcinia pedunculata as an inhibitor of gamma hemolysin component A of Staphylo-coccus aureus", Bangladesh J. Pharmacol, 9, pp.67~71 (2014)
49. Voyich JM, "Is Panton‐Valentine leukocidin the major virulence determinant in community‐associated methicillinresistant Staphylococcus aureus disease?", J. Infect. Dis, 194, pp.1761~1770 (2006)
50. Genestier A-L, "Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils", J. Clin. Investig, 115, pp.3117~3127 (2005)
51. McKevitt AI, "Amino acid sequence of a deltalike toxin from Staphylococcus epidermidis", Infect. Immun, 58, pp.1473~1475 (1990)
52. Wang R, "Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA", Nat. Med, 13, pp.1510~1514 (2007)
53. Tsompanidou E, "Distinct roles of phenol-soluble modulins in spreading of Staphylococcus aureus on wet surfaces", Appl. Environ. Microbiol, 79, pp.886~895 (2013)
54. Schwartz K, "Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms", PLoS Pathog, 8, pp.e1002744~ (2012)
55. Wang R, "Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilmassociated infection in mice", J. Clin. Invest, 121, pp.238~248 (2011)
56. Bukowski M, "Exfoliative toxins of Staphylococcus aureus", Toxins, 2, pp.1148~1165 (2010)
57. Holten KB, "Appropriate prescribing of oral beta-lactam antibiotics", Am. Fam. Physician, 62, pp.611~620 (2000)
58. Lobanovska M, "Focus: Drug development: Penicillin’s discovery and antibiotic resistance: Lessons for the future?", Yale J. Biol. Med, 90, pp.135~ (2017)
59. Hennekinne JA, "Staphylococcus aureus and its food poisoning toxins: characterization and outbreak investigation", FEMS Microbiol. Rev, 36, pp.815~836 (2012)
60. Lin C-F, "Different types of cell death induced by enterotoxins", Toxins, 2, pp.2158~2176 (2010)
61. Balaban N, "Staphylococcal enterotoxins", Int. J. Food Microbiol, 61, pp.1~10 (2000)
62. Rosenbach AJF., "Mikro-organismen bei den Wund-infectionskrankheiten des Menschen" (1884), Ed. JF Bergmann
63. Bischoff M, "Microarray-based analysis of the Staphylococcus aureus σB regulon", J. Bacteriol, 186, pp.4085~4099 (2004)
64. Ribeiro D, "Antioxidant and pro-oxidant activities of carotenoids and their oxidation products", Food Chem. Toxicol, 120, pp.681~699 (2018)
65. Siems W, "β-Carotene breakdown products may impair mitochondrial functions—potential side effects of high-dose β-carotene supplementation", J. Nutr. Biochem, 16, pp.385~397 (2005)
66. Fernandes A, "Introductory Chapter: Carotenoids - A brief overview on its structure, biosynthesis, synthesis, and applications, 1", pp.1~16 (2018)
67. Liu GY, "Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity", J. Exp. Med, 202, pp.209~215 (2005)[DOI]
68. Wieland B, "Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4'-diaponeurosporene of Staphylococcus aureus", J. Bacteriol, 176, pp.7719~7726 (1994)
69. Clauditz A, "Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress", Infect. Immun, 74, pp.4950~4953 (2006)
70. Beard-Pegler MA, "Observations on the resistance to drying of staphylococcal strains", J. Med. Microbiol, 26, pp.251~255 (1988)
71. Fang FC, "Antimicrobial reactive oxygen and nitrogen species: concepts and controversies", Nat. Rev. Microbiol, 2, pp.820~832 (2004)
72. Liu GY, "Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity", J. Exp. Med, 202, pp.209~215 (2005)
73. Liu C-I, "A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence", Science, 319, pp.1391~1394 (2008)
74. Popov I, "Study of the membranes of pigment-free mutant of Staphylococcus aureus", Biokhimiia (Moscow, Russia), 41, pp.1116~1120 (1976)
75. Mishra NN, "Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides", Antimicrob. Agents Chemother, 55, pp.526~531 (2011)
76. Bayer AS, "In vitro resistance of Staphylococcus aureus to thrombininduced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity", Infect. Immun, 68, pp.3548~3553 (2000)
77. Mitchell G, "SigB is a dominant regulator of virulence in Staphylococcus aureus small-colony variants", PLoS One, 8, pp.e65018~ (2013)
78. Arciola CR, "Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials", Biomaterials, 33, pp.5967~5982 (2012)
79. Marshall JH, "Proposed pathway of triterpenoid carotenoid biosynthesis in Staphylococcus aureus: evidence from a study of mutants", J. Bacteriol, 147, pp.914~919 (1981)
80. Palma M, "Sigma(B) activity in Staphylococcus aureus is controlled by RsbU and an additional factor(s) during bacterial growth", Infect. Immun, 69, pp.7858~7865 (2001)
81. Kullik I, "Deletion of the alternative sigma factor is sigma B Staphylococcus aureus reveals its function as a global regulator of virulence genes", J. Bacteriol, 180, pp.4814~4820 (1998)
82. Giachino P, "Sigma B activity depends on RsbU in Staphylococcus aureu", J. Bacteriol, 183, pp.1843~1852 (2001)
83. Liu Y, "SsrA(tmRNA)acts as an antisense RNA to regulate Staphylococcus aureus pigment synthesis by base pairing with crtMN mRNA", FEBS Lett, 584, pp.4325~4329 (2010)
84. Sen S, "Growth-environment dependent modulation of Staphylococcus aureus branched-chain to straight-chain fatty acid ratio and incorporation of unsaturated fatty acids", PLoS One, 11, pp.e0165300~ (2016)
85. Kullik I, "Deletion of the alternative sigma factor σB in Staphylococcus aureus reveals its function as a global regulator of virulence genes", J. Bacteriol, 180, pp.4814~4820 (1998)
86. van Schaik W, "The role of σB in the stress response of Gram-positive bacteria - targets for food preservation and safety", Curr. Opin. Biotechnol, 16, pp.218~224 (2005)
87. Katzif S, "CspA regulates pigment production in Staphylococcus aureus through a SigB-dependent mechanism", J. Bacteriol, 187, pp.8181~8184 (2005)
88. Hall JW, "The Staphylococcus aureus AirSR two-component system mediates reactive oxygen species resistance via transcriptional regulation of staphyloxanthin production", Infect. Immun, 85, pp.e00838~e01816 (2017)
89. Lan L, "Golden pigment production and virulence gene expression are affected by metabolisms in Staphylococcus aureus", J. Bacteriol, 192, pp.3068~3077 (2010)
90. Fey PD, "A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes", mBio, 4, pp.e00537~e01512 (2013)
91. Anderson KL, "Characterization of the Staphylococcus aureus heat shock, cold shock, stringent, and SOS responses and their effects on log-phase mRNA turnover", J. Bacteriol, 188, pp.6739~6756 (2006)
92. Hu B, "Modeling Hsp70-mediated protein folding", Biophys. J, 91, pp.496~507 (2006)
93. Craig EA, "The heat shock respons", Critc. Rev. Biochem, 18, pp.239~280 (1985)
94. Al Refaii A, "delayed in Escherichia coli lacking the chaperones", Mol. Microbiol, 71, pp.748~762 (2009)
95. Singh VK, "Roles of pyruvate dehydrogenase and branchedchain α-keto acid dehydrogenase in branched-chain membrane fatty acid levels and associated functions in Staphylococcus aureus", J. Med. Microbiol, 67, pp.570~ (2018)
96. Kakutani Y, "Detection of some isoprenoids and the influence of diphenylamine on the biosynthesis of isoprenoid by Sporobolomyces shibatanus", J. Biochem, 61, pp.193~198 (1967)
97. Hammond RK, "Inhibition of vitamin K2 and carotenoid synthesis in Staphylococcus aureus by diphenylamine", J. Bacteriol, 103, pp.611~615 (1970)
98. No JH, "Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity", Proc. Natl. Acad. Sci. USA, 109, pp.4058~4063 (2012)
99. Song Y, "Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results", J. Med. Chem, 52, pp.3869~3880 (2009)
100. Hammond RK, "Inhibition of vitamin K2 and carotenoid synthesis in Staphylococcus aureus by diphenylamine", J. Bacteriol, 103, pp.611~615 (1970)
101. Chen F, "Smallmolecule targeting of a diapophytoene desaturase inhibits S. aureus virulence", Nat. Chem. Biol, 12, pp.174~179 (2016)
102. Wang Y, "Discovery of Potent benzofuran-derived diapophytoene desaturase (CrtN) inhibitors with enhanced oral bioavailability for the treatment of methicillin-resistant Staphylococcus aureus (MRSA)infections", J. Med. Chem, 59, pp.3215~3230 (2016)
103. Cushnie TP, "Antimicrobial activity of flavonoids", Int. J. Antimicrob. Agents, 26, pp.343~356 (2005)
104. Lee J-H, "Flavone reduces the production of virulence factors, staphyloxanthin and α-Hemolysin, in Staphylococcus aureus", Curr. Microbiol, 65, pp.726~732 (2012)
105. Limsuwan S, "Boesenbergia pandurata (Roxb.) Schltr., Eleutherine americana Merr. and Rhodomyrtus tomentosa (Aiton) Hassk. as antibiofilm producing and antiquorum sensing in Streptococcus pyogenes", FEMS Immunol. Med. Microbiol, 53, pp.429~436 (2008)
106. Saising J, "Rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. as a natural antibiotic for Staphylococcal Cutaneous infections", J. Health Sci, 54, pp.589~595 (2008)
107. Leejae S, "Voravuthikunchai SP. 2013. Inhibition of staphyloxanthin biosynthesis in Staphylococcus aureus by rhodomyrtone, a novel antibiotic candidate", J. Med. Microbiol, 62, pp.421~428 (2013)
108. Sakai K, "Search method for inhibitors of Staphyloxanthin production by methicillin-resistant Staphylococcus aureus", Biol. Pharm. Bull, 35, pp.48~53 (2012)
109. Fukuda T, "Tylopilusin C, a new diphenolic compound from the fruiting bodies of Tylopilus eximinus", J. Antibiot, 66, pp.355~357 (2013)
110. Fukuda T, "Graphiumins, new thiodiketopiperazines from the marine-derived fungus Graphium sp. OPMF00224", J. Antibiot, 68, pp.620~627 (2015)
111. Fukuda T, "Synthesis and biological activity of Citridone A and its derivatives", J. Antibiot, 67, pp.445~450 (2014)

관련 논문AI추천